First Episode Psychosis
31
6
7
15
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 31 trials
100.0%
+13.5% vs benchmark
23%
7 trials in Phase 3/4
20%
3 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (31)
Digital Strategies to Advance Help-Seeking Aim 1 and 2
Digital Strategies to Advance Help-Seeking - Aim 3
Early Psychosis Intervention - Spreading Evidence-based Treatment
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
Optimizing Engagement in Services for First-Episode Psychosis
Thermoregulation Among Individuals With First-episode Psychosis
OnTrackNY's Learning Healthcare System
On Track for Wellness (OTW) Stepped Wedge Cluster Randomized Trial
Stratification and Treatment in Early Psychosis Study - ENHANCE
Recovery With Exogenous Ketones and Antipsychotics
Pilot RCT of Self-stigma Treatment for First Episode Psychosis
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
Artificial Intelligence to Measure Adherence to Oral Medication
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes
Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis
Evaluation of Case Management for First Episode Psychosis Using the PEPsy-CM Checklist
OnTrackNY With the Option of Social Network Meetings
Reducing the Duration of Untreated Psychosis